|
|
||||||||
Laboratoire dImmunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France
A number of Ags recognized by tumor-reactive T cells have been characterized, including nonmutated gene products and a variety of epitopes shown to arise from either mutated or alternatively processed transcripts. Here, we report that the screening of a cDNA library with an HLA-B7-restricted renal cell carcinoma-reactive T cell clone derived from tumor-infiltrating lymphocytes (TILs) that were clonally amplified in vivo (as assessed by TCRBV complementarity determining region-3 length distribution analysis) resulted in the isolation of a nonamer encoded by an alternative open reading frame (ORF) (a +1 frameshift) of the intestinal carboxyl esterase gene. This peptide binds HLA-B*0702-presenting molecules as assessed in an immunofluorescence-based peptide binding assay using transfected T2 cells. Constitutive expression of this alternative ORF protein was observed in all transformed HLA-B7+ renal cell lines that were recognized in cytotoxicity assays by the TILs. The intestinal carboxyl esterase gene is transcribed in renal cell carcinoma tumors as well as in normal liver, intestinal, or renal tissues. Mutation of the natural ATG translation initiation site did not alter recognition, indicating that frameshifting (i.e., slippage of the ribosome forward) and recoding are not involved. In addition, a point mutation of the three AUG codons that may be used as alternative translation initiation sites in the +1 ORF did not abolish recognition, whereas mutation of an upstream ACG codon did, indicating that the latter codon initiates the translation of the alternative ORF. These results further extend the types of Ags that can be recognized by tumor-reactive TILs in situ (i.e., leading to clonal T cell expansion).
This article has been cited by other articles:
![]() |
O. Ho and W. R. Green Alternative Translational Products and Cryptic T Cell Epitopes: Expecting the Unexpected J. Immunol., December 15, 2006; 177(12): 8283 - 8289. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tassi, V. Facchinetti, S. Seresini, A. Borri, G. Dell'Antonio, C. Garavaglia, G. Casorati, and M. P. Protti Peptidome from Renal Cell Carcinoma Contains Antigens Recognized by CD4+ T Cells and Shared among Tumors of Different Histology. Clin. Cancer Res., August 15, 2006; 12(16): 4949 - 4957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Zook, M. T. Howard, G. Sinnathamby, J. F. Atkins, and L. C. Eisenlohr Epitopes Derived by Incidental Translational Frameshifting Give Rise to a Protective CTL Response. J. Immunol., June 1, 2006; 176(11): 6928 - 6934. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, D. Y. Jun, A. M. Thomas, X. Huang, L.-Q. Huang, J. Mautner, W. Mo, P. F. Robbins, D. M. Pardoll, and E. M. Jaffee Diverse CD8+ T-Cell Responses to Renal Cell Carcinoma Antigens in Patients Treated with an Autologous Granulocyte-Macrophage Colony-Stimulating Factor Gene-Transduced Renal Tumor Cell Vaccine Cancer Res., February 1, 2005; 65(3): 1079 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dorrschuck, A. Schmidt, E. Schnurer, M. Gluckmann, C. Albrecht, C. Wolfel, V. Lennerz, A. Lifke, C. Di Natale, E. Ranieri, et al. CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression Blood, October 15, 2004; 104(8): 2591 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. Hogan, M. A. Coppola, C. L. Gatlin, L. W. Thompson, J. Shabanowitz, D. F. Hunt, V. H. Engelhard, M. M. Ross, and C. L. Slingluff Jr. Identification of Novel and Widely Expressed Cancer/Testis Gene Isoforms That Elicit Spontaneous Cytotoxic T-Lymphocyte Reactivity to Melanoma Cancer Res., February 1, 2004; 64(3): 1157 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Weinschenk, C. Gouttefangeas, M. Schirle, F. Obermayr, S. Walter, O. Schoor, R. Kurek, W. Loeser, K.-H. Bichler, D. Wernet, et al. Integrated Functional Genomics Approach for the Design of Patient-individual Antitumor Vaccines Cancer Res., October 15, 2002; 62(20): 5818 - 5827. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Hanada, D. M. Perry-Lalley, G. A. Ohnmacht, M. P. Bettinotti, and J. C. Yang Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas Cancer Res., July 1, 2001; 61(14): 5511 - 5516. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Probst-Kepper, V. Stroobant, R. Kridel, B. Gaugler, C. Landry, F. Brasseur, J.-P. Cosyns, B. Weynand, T. Boon, and B. J. Van den Eynde An Alternative Open Reading Frame of the Human Macrophage Colony-Stimulating Factor Gene Is Independently Translated and Codes for an Antigenic Peptide of 14 Amino Acids Recognized by Tumor-Infiltrating Cd8 T Lymphocytes J. Exp. Med., May 21, 2001; 193(10): 1189 - 1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rimoldi, V. Rubio-Godoy, V. Dutoit, D. Lienard, S. Salvi, P. Guillaume, D. Speiser, E. Stockert, G. Spagnoli, C. Servis, et al. Efficient Simultaneous Presentation of NY-ESO-1/LAGE-1 Primary and Nonprimary Open Reading Frame-Derived CTL Epitopes in Melanoma J. Immunol., December 15, 2000; 165(12): 7253 - 7261. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu and E. Celis Use of Two Predictive Algorithms of the World Wide Web for the Identification of Tumor-reactive T-Cell Epitopes Cancer Res., September 1, 2000; 60(18): 5223 - 5227. [Abstract] [Full Text] |
||||
![]() |
A. Moreau-Aubry, S. Le Guiner, N. Labarriere, M.-C. Gesnel, F. Jotereau, and R. Breathnach A Processed Pseudogene Codes for a New Antigen Recognized by a Cd8+ T Cell Clone on Melanoma J. Exp. Med., May 1, 2000; 191(9): 1617 - 1624. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Guerra, M. Guillard, E. Angevin, H. Echchakir, B. Escudier, A. Moretta, S. Chouaib, and A. Caignard Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas Blood, May 1, 2000; 95(9): 2883 - 2889. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |